Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Users Online: 558 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Low serum iron as a possible risk factor for neuroleptic malignant syndrome

Patil Bhushan Subhash, Subramanyam Alka A, Singh Shipra L, Kamath Ravindra M

Year : 2014| Volume: 4| Issue : 2 | Page no: 117-118

   This article has been cited by
1 Case Report: Neuroleptic malignant syndrome in a HIV-positive patient
Sibi Joseph,Jerry George,Mongezi Tau,Lourdes de Fatima Ibanez-Valdes,Thozama Dubula,Humberto Foyaca-Sibat
F1000Research. 2020; 9: 1382
[Pubmed]  [Google Scholar] [DOI]
2 Prevalence of Extended Spectrum Betalactamase (ESBL) and Metallobetalactamase (MBL) Producing Pseudomonas aeruginosa and Acinetobacter baumannii Isolated from Various Clinical Samples
Amandeep Kaur,Satnam Singh
Journal of Pathogens. 2018; 2018: 1
[Pubmed]  [Google Scholar] [DOI]
3 Management of common adverse effects of antipsychotic medications
T. Scott Stroup,Neil Gray
World Psychiatry. 2018; 17(3): 341
[Pubmed]  [Google Scholar] [DOI]
4 Neuroleptic malignant syndrome: A neuro-psychiatric emergency: Recognition, prevention, and management
Raj Velamoor
Asian Journal of Psychiatry. 2017; 29: 106
[Pubmed]  [Google Scholar] [DOI]
5 Ferrosenescence: The iron age of neurodegeneration?
Adonis Sfera,Kelsey Bullock,Amy Price,Luzmin Inderias,Carolina Osorio
Mechanisms of Ageing and Development. 2017;
[Pubmed]  [Google Scholar] [DOI]
6 A Case of "Brief" Aripiprazole-induced Neuroleptic Malignant Syndrome with Symptoms that Only Lasted a Few Hours
Naoto Mizumura,Masato Uematu,Aya Ito,Satoshi Okumura,Hiromitsu Maehira,Masao Ogawa,Masayasu Kawasaki
Internal Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article